Legion Metals Corp Share Price Canadian Securities Exchange
Equities
CA52490L1013
Pharmaceuticals
Sales 2022 | 4.41M 3.22M 258M | Sales 2023 | 8.18M 5.98M 479M | Capitalization | 9.57M 6.99M 560M |
---|---|---|---|---|---|
Net income 2022 | -3M -2.19M -176M | Net income 2023 | - 0 0 | EV / Sales 2022 | 2.66 x |
Net Debt 2022 | 985K 720K 57.68M | Net cash position 2023 | 409K 299K 23.96M | EV / Sales 2023 | 1.12 x |
P/E ratio 2022 |
-2.5
x | P/E ratio 2023 |
41
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.84% |
Managers | Title | Age | Since |
---|---|---|---|
Emma Andrews
CEO | Chief Executive Officer | - | 31/05/18 |
Sam Kassem
DFI | Director of Finance/CFO | - | 30/05/22 |
Catherine Marion
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Bonner
BRD | Director/Board Member | 62 | 13/03/19 |
Emma Andrews
CEO | Chief Executive Officer | - | 31/05/18 |
Sherry Boodram
BRD | Director/Board Member | - | 15/10/19 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |